JAAD Case Reports

Elsevier

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

JAAD Case Reports is an open-access journal published by Elsevier in Netherlands, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 850 USD. Declared review time at DOAJ: 24 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier
ISSN
2352-5126
Country
Netherlands
Languages
english
Access
Open access
Declared publication charge
850 USD
Articles in DOAJ
3310
Declared review time
24 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2016-09-13
Indexing
DOAJ
APC
850 USD
Declared review time (DOAJ)
24 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

3310

Most recent article

last month

Average review time (journal-declared via DOAJ)

24weeks

Works in OpenAlex

4906

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

44

i10-index

696

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2026-04-27
Added to DOAJ
2016-09-13
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
94%
ORCID iDs in current deposits
36%
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Source type
journal
NLM unique ID (PubMed)
101665210
Classification2

Subjects (DOAJ)

Medicine: Dermatology

LCC codes

RL1-803

Subject areas

  • Dermatology and Skin Diseases
  • Autoimmune Bullous Skin Diseases
  • Autoimmune Bullous Skin Diseases
  • Skin Diseases and Diabetes
  • Drug-Induced Adverse Reactions
  • Cancer and Skin Lesions
  • Cutaneous lymphoproliferative disorders research
  • Cutaneous lymphoproliferative disorders research
Show all subjects (75)
  • Nonmelanoma Skin Cancer Studies
  • Autoimmune and Inflammatory Disorders
  • Cancer and Skin Lesions
  • Cancer and Skin Lesions
  • Genetic and rare skin diseases.
  • Dermatological and COVID-19 studies
  • Autoimmune and Inflammatory Disorders
  • Autoimmune and Inflammatory Disorders
  • Cutaneous lymphoproliferative disorders research
  • Genetic and rare skin diseases.
  • Autoimmune Bullous Skin Diseases
  • Skin Diseases and Diabetes
  • Genetic and rare skin diseases.
  • Skin Diseases and Diabetes
  • Medicine and Dermatology Studies History
  • Chemotherapy-related skin toxicity
  • Nonmelanoma Skin Cancer Studies
  • Nonmelanoma Skin Cancer Studies
  • Urticaria and Related Conditions
  • Urticaria and Related Conditions
  • Drug-Induced Adverse Reactions
  • Eosinophilic Disorders and Syndromes
  • Eosinophilic Disorders and Syndromes
  • Drug-Induced Adverse Reactions
  • Nail Diseases and Treatments
  • Nail Diseases and Treatments
  • melanin and skin pigmentation
  • Cutaneous Melanoma Detection and Management
  • Dermatology and Skin Diseases
  • Dermatology and Skin Diseases
  • Psoriasis: Treatment and Pathogenesis
  • Histiocytic Disorders and Treatments
  • Hair Growth and Disorders
  • Diverse Scientific and Economic Studies
  • Diverse Scientific and Economic Studies
  • Vasculitis and related conditions
  • Oral Health Pathology and Treatment
  • Oral Health Pathology and Treatment
  • Skin and Cellular Biology Research
  • Dermatological and Skeletal Disorders
  • Systemic Sclerosis and Related Diseases
  • Dermatological and Skeletal Disorders
  • Hair Growth and Disorders
  • Lymphoma Diagnosis and Treatment
  • Hair Growth and Disorders
  • Chemotherapy-related skin toxicity
  • Cancer Immunotherapy and Biomarkers
  • Inflammatory Myopathies and Dermatomyositis
  • Cutaneous Melanoma Detection and Management
  • Chemotherapy-related skin toxicity
  • Fungal Infections and Studies
  • Fungal Infections and Studies
  • Inflammatory Myopathies and Dermatomyositis
  • Cutaneous Melanoma Detection and Management
  • Skin and Cellular Biology Research
  • Dermatologic Treatments and Research
  • Dermatologic Treatments and Research
  • Hidradenitis Suppurativa and Treatments
  • Skin and Cellular Biology Research
  • Oral Health Pathology and Treatment
  • Hidradenitis Suppurativa and Treatments
  • Vascular Malformations and Hemangiomas
  • Psoriasis: Treatment and Pathogenesis
  • Dermatological and COVID-19 studies
  • Nail Diseases and Treatments
  • Psoriasis: Treatment and Pathogenesis
  • Dermatological and COVID-19 studies

Keywords (DOAJ)

  • dermatology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: